Stride price target lowered to $125 from $185 at Barrington

Barrington lowered the firm’s price target on Stride (LRN) to $125 from $185 and keeps an Outperform rating on the shares post the fiscal Q1 report. The company’s initial fiscal 2026 outlook came in significantly below expectations, the analyst tells investors in a research note. “The damage has been done” but the shares should find support at current levels based on current estimates, adds Barrington. The firm points out that management believes the worst is behind Stride.